Prosecution Insights
Last updated: April 19, 2026

Verve Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18470264 COMPOSITIONS AND METHODS FOR TARGETED RNA DELIVERY ALLEY, GENEVIEVE S 1617 Non-Final OA Sep 19, 2023
17918069 CHEMICALLY MODIFIED GUIDE RNAS FOR GENOME EDITING WITH CAS9 BABIC, CHRISTOPHER M 1633 Non-Final OA Oct 10, 2022

Managing Verve Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month